Asymmetrical dimethylarginine plasma clearance persists after acute total nephrectomy in rats

被引:40
作者
Carello, KA
Whitesall, SE
Lloyd, MC
Billecke, SS
D'Alecy, LG
机构
[1] Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Sch Med, Dept Surg Vasc, Ann Arbor, MI 48109 USA
[3] William Beaumont Hosp, Dept Surg, Royal Oak, MI USA
来源
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY | 2006年 / 290卷 / 01期
关键词
nitric oxide synthase inhibitor; dimethylarginine dimethylaminohydrolase; source of asymmetrical dimethylarginine;
D O I
10.1152/ajpheart.00208.2005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Elevated plasma concentrations of symmetrical dimethylarginine (SDMA) and asymmetrical dimethylarginine (ADMA) are repeatedly associated with kidney failure. Both ADMA and SDMA can be excreted in urine. We tested whether renal excretion is necessary for acute, short- term maintenance of plasma ADMA and SDMA. Sprague- Dawley rats underwent sham operation, bilateral nephrectomy (NPX), ureteral ligation, or ureteral section under isoflurane anesthesia. Tail- snip blood samples (250 mu l) were taken before and at 6- or 12-h intervals for 72 h after operation. Plasma clearance was assessed in intact and NPX rats. High- performance liquid chromatography determined SDMA and ADMA concentrations. Sodium, potassium, creatinine, blood urea nitrogen (BUN), and body weight were also measured. Forty- eight hours after NPX, SDMA increased 25 times (0.23 +/- 0.03 to 5.68 +/- 0.30 mu M), whereas ADMA decreased (1.17 +/- 0.08 to 0.73 +/- 0.08 mu M) by 38%. Creatinine and BUN increased, paralleling SDMA. Sham- operated animals showed no significant changes. Increased SDMA confirms continuous systemic production of SDMA and its obligatory renal excretion, much like creatinine. In contrast, decreased plasma ADMA suggests that acute total NPX either reduced systemic ADMA formation and/ or systemic hydrolysis of ADMA increased 48-h post-NPX. However, plasma clearance of ADMA appeared unchanged 48 h after NPX. We conclude that renal excretory function is needed for SDMA elimination but not needed for acute, short- term ADMA elimination in that systemic hydrolysis is fully capable of clearing plasma ADMA.
引用
收藏
页码:H209 / H216
页数:8
相关论文
共 70 条
[1]   Asymmetric dimethylarginine causes hypertension and cardiac dysfunction in humans and is actively metabolized by dimethylarginine dimethylaminohydrolase [J].
Achan, V ;
Broadhead, M ;
Malaki, M ;
Whitley, G ;
Leiper, J ;
MacAllister, R ;
Vallance, P .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2003, 23 (08) :1455-1459
[2]   CIRCULATING ANGIOTENSIN-II AND ADRENAL RECEPTORS AFTER NEPHRECTOMY [J].
AGUILERA, G ;
SCHIRAR, A ;
BAUKAL, A ;
CATT, KJ .
NATURE, 1981, 289 (5797) :507-509
[3]   NG, NG-dimethylarginine and NG, N′G-dimethylarginine in renal insufficiency [J].
Al Banchaabouchi, M ;
Marescau, B ;
Possemiers, I ;
D'Hooge, R ;
Levillain, O ;
De Deyn, PP .
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 2000, 439 (05) :524-531
[4]  
ANEMAN A, 1994, CIRC SHOCK, V44, P111
[5]   Partial ureteral obstruction dysregulates the renal renin-angiotensin system in the fetal sheep kidney [J].
Ayan, S ;
Roth, JA ;
Freeman, MR ;
Bride, SH ;
Peters, CA .
UROLOGY, 2001, 58 (02) :301-306
[6]   Asymmetric dimethylarginine (ADMA):: A novel risk factor for endothelial dysfunction -: Its role in hypercholesterolemia [J].
Böger, RH ;
Bode-Böger, SM ;
Szuba, A ;
Tsao, PS ;
Chan, JR ;
Tangphao, O ;
Blaschke, TF ;
Cooke, JP .
CIRCULATION, 1998, 98 (18) :1842-1847
[7]   Biochemical evidence for impaired nitric oxide synthesis in patients with peripheral arterial occlusive disease [J].
Boger, RH ;
BodeBoger, SM ;
Thiele, W ;
Junker, W ;
Alexander, K ;
Frolich, JC .
CIRCULATION, 1997, 95 (08) :2068-2074
[8]   BRADYKININ AND ATP STIMULATE L-ARGININE UPTAKE AND NITRIC-OXIDE RELEASE IN VASCULAR ENDOTHELIAL-CELLS [J].
BOGLE, RG ;
COADE, SB ;
MONCADA, S ;
PEARSON, JD ;
MANN, GE .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1991, 180 (02) :926-932
[9]   NEPHRECTOMY, CONVERTING-ENZYME INHIBITION, AND ANGIOTENSIN PEPTIDES [J].
CAMPBELL, DJ ;
KLADIS, A ;
DUNCAN, AM .
HYPERTENSION, 1993, 22 (04) :513-522
[10]   Interference of L-arginine analogues with L-arginine transport mediated by the y+ carrier hCAT-2B [J].
Closs, EI ;
Basha, FZ ;
Habermeier, A ;
Forstermann, U .
NITRIC OXIDE-BIOLOGY AND CHEMISTRY, 1997, 1 (01) :65-73